annual total liabilities:
$1.24B+$19.60M(+1.60%)Summary
- As of today (September 16, 2025), RARE annual total liabilities is $1.24 billion, with the most recent change of +$19.60 million (+1.60%) on December 31, 2024.
- During the last 3 years, RARE annual total liabilities has risen by +$632.38 million (+103.88%).
- RARE annual total liabilities is now at all-time high.
Performance
RARE Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$1.15B-$12.70M(-1.09%)Summary
- As of today (September 16, 2025), RARE quarterly total liabilities is $1.15 billion, with the most recent change of -$12.70 million (-1.09%) on June 30, 2025.
- Over the past year, RARE quarterly total liabilities has dropped by -$38.04 million (-3.21%).
- RARE quarterly total liabilities is now -7.51% below its all-time high of $1.24 billion, reached on December 31, 2024.
Performance
RARE quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
RARE Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.6% | -3.2% |
| 3 y3 years | +103.9% | +78.7% |
| 5 y5 years | +153.6% | +85.6% |
RARE Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +103.9% | -7.5% | +78.7% |
| 5 y | 5-year | at high | +153.6% | -7.5% | +112.5% |
| alltime | all time | at high | >+9999.0% | -7.5% | >+9999.0% |
RARE Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $1.15B(-1.1%) |
| Mar 2025 | - | $1.16B(-6.5%) |
| Dec 2024 | $1.24B(+1.6%) | $1.24B(+4.8%) |
| Sep 2024 | - | $1.18B(-0.1%) |
| Jun 2024 | - | $1.19B(+1.6%) |
| Mar 2024 | - | $1.17B(-4.5%) |
| Dec 2023 | $1.22B(+1.9%) | $1.22B(+1.3%) |
| Sep 2023 | - | $1.21B(+2.0%) |
| Jun 2023 | - | $1.18B(+1.7%) |
| Mar 2023 | - | $1.16B(-3.0%) |
| Dec 2022 | $1.20B(+97.0%) | $1.20B(+4.3%) |
| Sep 2022 | - | $1.15B(+78.9%) |
| Jun 2022 | - | $642.55M(+9.4%) |
| Mar 2022 | - | $587.61M(-3.5%) |
| Dec 2021 | $608.78M(-4.7%) | $608.78M(+10.5%) |
| Sep 2021 | - | $551.13M(+2.0%) |
| Jun 2021 | - | $540.27M(-0.5%) |
| Mar 2021 | - | $543.18M(-14.9%) |
| Dec 2020 | $638.53M(+30.5%) | $638.53M(+6.0%) |
| Sep 2020 | - | $602.19M(-2.6%) |
| Jun 2020 | - | $618.45M(-0.9%) |
| Mar 2020 | - | $623.99M(+27.5%) |
| Dec 2019 | $489.39M | $489.39M(+220.5%) |
| Sep 2019 | - | $152.68M(+9.7%) |
| Jun 2019 | - | $139.14M(+15.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $121.03M(+9.4%) |
| Dec 2018 | $110.65M(+3.1%) | $110.65M(+7.9%) |
| Sep 2018 | - | $102.55M(+0.5%) |
| Jun 2018 | - | $102.05M(+8.9%) |
| Mar 2018 | - | $93.69M(-12.7%) |
| Dec 2017 | $107.30M(+61.0%) | $107.30M(+54.4%) |
| Sep 2017 | - | $69.49M(+2.1%) |
| Jun 2017 | - | $68.09M(+18.7%) |
| Mar 2017 | - | $57.34M(-14.0%) |
| Dec 2016 | $66.65M(+134.0%) | $66.65M(+12.4%) |
| Sep 2016 | - | $59.28M(+55.8%) |
| Jun 2016 | - | $38.06M(+10.8%) |
| Mar 2016 | - | $34.36M(+20.7%) |
| Dec 2015 | $28.48M(+118.7%) | $28.48M(+12.3%) |
| Sep 2015 | - | $25.37M(+6.9%) |
| Jun 2015 | - | $23.73M(+61.2%) |
| Mar 2015 | - | $14.72M(+13.0%) |
| Dec 2014 | $13.02M(+36.5%) | $13.02M(+12.2%) |
| Sep 2014 | - | $11.61M(+22.1%) |
| Jun 2014 | - | $9.50M(+35.9%) |
| Mar 2014 | - | $6.99M(-26.7%) |
| Dec 2013 | $9.54M(+139.9%) | $9.54M(+28.3%) |
| Sep 2013 | - | $7.44M(+42.9%) |
| Jun 2013 | - | $5.21M(+30.9%) |
| Dec 2012 | $3.98M(+167.6%) | $3.98M |
| Dec 2011 | $1.49M | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual total liabilities?
- What is the all time high annual total liabilities for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual total liabilities year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly total liabilities?
- What is the all time high quarterly total liabilities for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly total liabilities year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual total liabilities?
The current annual total liabilities of RARE is $1.24B
What is the all time high annual total liabilities for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual total liabilities is $1.24B
What is Ultragenyx Pharmaceutical Inc. annual total liabilities year-on-year change?
Over the past year, RARE annual total liabilities has changed by +$19.60M (+1.60%)
What is Ultragenyx Pharmaceutical Inc. quarterly total liabilities?
The current quarterly total liabilities of RARE is $1.15B
What is the all time high quarterly total liabilities for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly total liabilities is $1.24B
What is Ultragenyx Pharmaceutical Inc. quarterly total liabilities year-on-year change?
Over the past year, RARE quarterly total liabilities has changed by -$38.04M (-3.21%)